Lung cancer in non-smokers a separate disease

Oct. 10, 2008

NEW YORK (Reuters Health) - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.

Lifestyle, screening key to cancer decline

BOSTON, Dec. 3 (UPI) -- Healthier lifestyle choices and screening have contributed greatly to the 13 percent decline in U.S. cancer mortality since 1990, a researcher said.

Bone loss due to more than cancer drugs

CHICAGO, Nov. 21 (UPI) -- Certain cancer drugs can cause bone loss in breast cancer survivors, but cancer drugs aren't the only culprits, U.S. researchers said.

Merle Haggard home following surgery

BAKERSFIELD, Calif., Nov. 9 (UPI) -- Country music icon Merle Haggard has returned home following lung cancer surgery last week at a hospital in Bakersfield, Calif., a publicist said Sunday.

Lung cancer genes decoded

ST. LOUIS, Nov. 5 (UPI) -- U.S. researchers said they've decoded the genetic changes associated with a common form of lung cancer.

New cancer drug is called impressive

GENEVA, Switzerland, Oct. 23 (UPI) -- U.S. scientists say an early trial of a multi-kinase inhibitor has shown impressive tumor shrinkage in patients with a hard-to-treat form of thyroid cancer.

Study: Wealth affects cancer rate

MANCHESTER, England, Sept. 26 (UPI) -- Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy, British researchers said.

Asian lung cancer therapy studied

HONG KONG, Sept. 17 (UPI) -- Chinese medical scientists say the drug gefitinib (Iressa) should be considered the first-line therapy for non-smoking Asian patients with lung cancer.

Lung cancer in never-smokers higher in men

ATLANTA, Sept. 12 (UPI) -- Men who reported never smoking have a 1.1 percent risk of dying from lung cancer before age 85, and women 0.8 percent, U.S. researchers said.

Racial lung cancer models aid predictions

HOUSTON, Sept. 9 (UPI) -- U.S. medical scientists say they've developed the first lung cancer risk model for African-Americans.

Serum microRNAs: Biomarkers for cancer?

NANJING, China, Sept. 8 (UPI) -- Chinese medical scientists say they've discovered serum microRNAs, or miRNAs, can serve as biomarkers for the detection of such diseases as cancer and diabetes.

African-American COPD links to lung cancer

HOUSTON, Sept. 7 (UPI) -- U.S. researchers say African-Americans with a prior history of chronic obstructive pulmonary disease had a six-fold increased risk of lung cancer.

CDC: Native American cancer rates differ

ATLANTA, Aug. 20 (UPI) -- Lung and colorectal cancer incidence rates among American Indian and Alaska Native, or AI/AN men and women varies greatly nationwide, U.S. officials said.

New chemo shows promise in lung cancer

OSAKA, Japan, Aug. 12 (UPI) -- A Japanese-led study suggests an experimental combination of chemotherapy agents might be a good alternative to standard lung cancer treatment.

Study: Higher education, lower cancer risk

WASHINGTON, July 14 (UPI) -- Higher education is good for the mind, and new research by the American Cancer Society says it's good for the body as well.

Smoking/bladder cancer link not realized

ANN ARBOR, Mich., July 9 (UPI) -- Cigarette smoking accounts for up to half of all bladder cancer cases, but few people are aware of the connection, U.S. researchers said.